Propranolol Titration for Akathisia
Start propranolol at 30 mg daily in divided doses (10 mg three times daily) and titrate upward by 10-20 mg every 1-2 days based on response, with most patients responding to 30-80 mg/day within 24 hours. 1
Initial Dosing Strategy
- Begin with 30 mg/day divided into 2-3 doses (e.g., 10 mg three times daily or 15 mg twice daily), as this represents the lower end of the effective range demonstrated in clinical trials 1
- Response typically occurs rapidly, within 24 hours in most patients, so you can assess efficacy quickly 1
- The effective dose range for akathisia is notably lower than for other indications: 30-80 mg/day is sufficient for most patients 1
Titration Schedule
- Increase by 10-20 mg every 1-2 days if akathisia persists, monitoring for both therapeutic response and adverse effects 1
- Most patients achieve complete or substantial remission at doses between 30-80 mg/day 1
- Maximum dose rarely needs to exceed 80 mg/day for akathisia, unlike anxiety or cardiovascular indications where higher doses may be required 2
Pre-Treatment Assessment (Mandatory)
Before initiating propranolol, you must screen for absolute contraindications:
- Asthma or obstructive airway disease (auscultate lungs for wheezing) 3
- Second or third-degree heart block (obtain baseline ECG if cardiac history is concerning) 2
- Decompensated heart failure 2
- Sinus bradycardia (baseline heart rate <50-55 bpm) 3
- Hypotension (baseline systolic BP <90 mmHg) 3
- Recent hypoglycemic episodes (particularly in diabetic patients, as propranolol masks hypoglycemia symptoms) 2, 3
Obtain baseline vital signs including heart rate and blood pressure before the first dose 2, 3
Administration Guidelines
- Administer with food to reduce hypoglycemia risk, even though this is less critical in adults than pediatric populations 3
- Divide total daily dose into 2-3 administrations using immediate-release formulation (half-life 3-6 hours requires multiple daily dosing) 2
- Hold doses if the patient develops acute illness with reduced oral intake or vomiting 3
Monitoring During Titration
- Measure heart rate and blood pressure before each dose increase, particularly watching for bradycardia (<50-55 bpm) or hypotension (systolic BP <90 mmHg) 2
- Monitor for orthostatic hypotension, especially in elderly patients or those on concurrent antipsychotics 4
- Assess akathisia severity at each visit using objective measures (e.g., Barnes Akathisia Rating Scale) to guide titration 4
- No routine laboratory monitoring is required in otherwise healthy patients 2
Common Pitfalls and Caveats
Propranolol has modest evidence for akathisia despite being considered "first-line" - the evidence base is surprisingly limited, with most data from small open-label trials 4. Alternative agents like low-dose mirtazapine (7.5-15 mg daily) have shown compelling evidence and may be considered if propranolol is contraindicated or ineffective 4
Beta-1 selective agents (metoprolol, betaxolol) are equally effective at doses of 25-100 mg/day for metoprolol or 10-20 mg/day for betaxolol, suggesting beta-1 blockade is sufficient 5, 6. Consider these alternatives in patients with mild reactive airway disease where non-selective beta blockade is relatively contraindicated 5
Propranolol's side effects limit use in some patients, including orthostatic hypotension (particularly problematic when combined with antipsychotics), bradycardia, and fatigue 4. The increased complexity of titration compared to alternatives is a legitimate concern 4
Never abruptly discontinue propranolol after chronic use - taper gradually over 1-3 weeks to prevent rebound tachycardia, hypertension, or worsening akathisia 2, 3
Drug Interactions
- Avoid combining with non-dihydropyridine calcium channel blockers (diltiazem, verapamil) due to additive effects on cardiac conduction and increased risk of severe bradycardia or heart block 2
- Use caution with other medications that lower heart rate or blood pressure, including other antihypertensives and certain antipsychotics 2
Special Populations
Elderly patients may require lower starting doses (e.g., 10 mg twice daily) due to altered pharmacokinetics and increased sensitivity to beta blockade 2
Diabetic patients require extra caution as propranolol masks tachycardia and tremor associated with hypoglycemia, potentially delaying recognition of dangerous blood sugar drops 2, 3
Alternative Approach for Non-Responders
If no response occurs at 80 mg/day after 2-3 days, consider: